Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS)
- PMID: 19688669
- DOI: 10.1055/s-0028-1109672
Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS)
Abstract
Aim: To evaluate the incidence and diagnostic accuracy of tumor-specific vascularization pattern in contrast-enhanced ultrasound (CEUS) in the differential diagnosis of liver tumors in clinical practice.
Materials and methods: From May 2004 to December 2006 1349 patients (male 677, female 672) with a hepatic tumor lacking a definite diagnosis based on B-mode ultrasound and power Doppler ultrasound were examined at 14 hospitals by CEUS using a standardized protocol (pulse/phase inversion imaging, mechanical index < 0.4). Vascularity pattern and contrast enhancement pattern were analyzed in focal lesions during the arterial, portal, and late phase. The tumor-specific diagnosis established after CEUS was compared to histology (> 75 % cases) or in some cases to CT or MRI.
Results: The final diagnosis of 573 benign hepatic tumors included hemangiomas (n = 242) and focal nodular hyperplasia (n = 170), other benign lesions (n = 161). Tumor-specific vascularization pattern such as a wheel-spoke pattern and arterial hyperenhancement followed by isoenhancement in the late phase in FNH or a nodular peripheral enhancement and partial or complete fill-in pattern in hemangiomas could be assessed in the majority, but not all lesions. The diagnostic accuracy of CEUS was 83.1 % for all benign lesions and 82.2 % for hemangioma and 87.1 % for FNH. The final diagnosis of 755 malignant hepatic tumors included metastases n = 383, hepatocellular carcinoma n = 279 and other malignant lesions n = 93. Late phase hypoenhancement was seen in almost all liver metastases (94.7 %) The diagnostic accuracy of CEUS was 95.8 % for all malignant lesions and 91.4 % for liver metastases and 84.9 % for hepatocellular carcinomas.
Conclusion: Tumor-specific vascularization pattern in CEUS have a high diagnostic impact on the overall high diagnostic accuracy of CEUS for the differential diagnosis of hepatic tumors in clinical practice.
(c) Georg Thieme Verlag KG Stuttgart, New York.
Similar articles
-
Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.Ultraschall Med. 2009 Aug;30(4):383-9. doi: 10.1055/s-0028-1109673. Epub 2009 Aug 17. Ultraschall Med. 2009. PMID: 19688670
-
Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.Ultraschall Med. 2010 Dec;31(6):577-81. doi: 10.1055/s-0029-1245649. Epub 2010 Aug 25. Ultraschall Med. 2010. PMID: 20740399
-
Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.Ultraschall Med. 2010 Oct;31(5):492-9. doi: 10.1055/s-0029-1245591. Epub 2010 Jul 22. Ultraschall Med. 2010. PMID: 20652854
-
Liver tumor characterization--comments and illustrations regarding guidelines.Ultraschall Med. 2012 Jul;33 Suppl 1:S22-30. doi: 10.1055/s-0032-1312892. Epub 2012 Jun 21. Ultraschall Med. 2012. PMID: 22723025 Review.
-
Liver tumor characterization--review of the literature.Ultraschall Med. 2012 Jul;33 Suppl 1:S3-10. doi: 10.1055/s-0032-1312897. Epub 2012 Jun 21. Ultraschall Med. 2012. PMID: 22723026 Review.
Cited by
-
Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.Eur Radiol. 2021 Oct;31(10):7614-7625. doi: 10.1007/s00330-021-07872-3. Epub 2021 Apr 15. Eur Radiol. 2021. PMID: 33855588 Free PMC article.
-
Contrast-enhanced ultrasound-guided musculoskeletal biopsies: our experience and technique.Skeletal Radiol. 2021 Apr;50(4):673-681. doi: 10.1007/s00256-020-03604-8. Epub 2020 Sep 15. Skeletal Radiol. 2021. PMID: 32935196
-
Contrast vector imaging for differential diagnosis of focal liver lesions: Analysis of tumoral vascular structures and flow characteristics.PLoS One. 2024 Dec 3;19(12):e0314263. doi: 10.1371/journal.pone.0314263. eCollection 2024. PLoS One. 2024. PMID: 39625940 Free PMC article.
-
Utilization of Contrast-Enhanced Ultrasound in Diagnosis of Focal Liver Lesions.Int J Hepatol. 2024 Oct 24;2024:3879328. doi: 10.1155/2024/3879328. eCollection 2024. Int J Hepatol. 2024. PMID: 39484627 Free PMC article.
-
Is hepatotropic contrast enhanced MR a more effective method in differential diagnosis of hemangioma than multi-phase CT and unenhanced MR?BMC Gastroenterol. 2011 Apr 19;11:43. doi: 10.1186/1471-230X-11-43. BMC Gastroenterol. 2011. PMID: 21504593 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical